Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China

NCT02040246 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Repaglinide
DRUG: Metformin

Sponsor

RenJi Hospital